| Nov 5 |
Verona Pharma (NASDAQ:VRNA) shareholder returns have been incredible, earning 724% in 5 years
|
| Nov 5 |
Verona Pharma PLC (VRNA) Q3 2024 Earnings Call Highlights: Strong Ohtuvayre Launch Amid Rising Costs
|
| Nov 5 |
Verona Pharma to Present at Jefferies London Healthcare Conference
|
| Nov 4 |
Verona Pharma plc (VRNA) Q3 2024 Earnings Call Transcript
|
| Nov 4 |
Verona Pharma reports Q3 results
|
| Nov 4 |
Verona Pharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update
|
| Nov 1 |
Verona Pharma Q3 2024 Earnings Preview
|
| Oct 25 |
Recent Price Trend in Verona Pharma (VRNA) is Your Friend, Here's Why
|
| Oct 25 |
Zacks Industry Outlook Highlights Exelixis, Blueprint Medicines, CRISPR, Amicus and Verona Pharma
|
| Oct 24 |
5 Biotech Stocks Likely to Outperform as Industry Prospects Look Bright
|
